• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌的前驱病变

Precursors to pancreatic cancer.

作者信息

Hruban Ralph H, Maitra Anirban, Kern Scott E, Goggins Michael

机构信息

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

出版信息

Gastroenterol Clin North Am. 2007 Dec;36(4):831-49, vi. doi: 10.1016/j.gtc.2007.08.012.

DOI:10.1016/j.gtc.2007.08.012
PMID:17996793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2194627/
Abstract

Infiltrating ductal adenocarcinoma of the pancreas is believed to arise from morphologically distinct noninvasive precursor lesions. These precursors include the intraductal papillary mucinous neoplasm, the mucinous cystic neoplasm, and pancreatic intraepithelial neoplasia. Intraductal papillary mucinous neoplasms are grossly visible mucin-producing epithelial neoplasms that arise in the main pancreatic duct or one of its branches. The cysts of mucinous cystic neoplasms do not communicate with the major pancreatic ducts, and these neoplasms are characterized by a distinct ovarian-type stroma. Pancreatic intraepithelial neoplasia is a microscopic lesion. This article focuses on the clinical significance of these three important precursor lesions, with emphasis on their clinical manifestations, detection, and treatment.

摘要

胰腺浸润性导管腺癌被认为起源于形态学上不同的非侵袭性前驱病变。这些前驱病变包括导管内乳头状黏液性肿瘤、黏液性囊性肿瘤和胰腺上皮内瘤变。导管内乳头状黏液性肿瘤是肉眼可见的产生黏液的上皮性肿瘤,发生于主胰管或其分支之一。黏液性囊性肿瘤的囊肿不与主胰管相通,这些肿瘤的特征是具有独特的卵巢型间质。胰腺上皮内瘤变是一种微观病变。本文重点关注这三种重要前驱病变的临床意义,重点在于它们的临床表现、检测和治疗。

相似文献

1
Precursors to pancreatic cancer.胰腺癌的前驱病变
Gastroenterol Clin North Am. 2007 Dec;36(4):831-49, vi. doi: 10.1016/j.gtc.2007.08.012.
2
Clinical importance of precursor lesions in the pancreas.胰腺前驱病变的临床重要性。
J Hepatobiliary Pancreat Surg. 2007;14(3):255-63. doi: 10.1007/s00534-006-1170-9. Epub 2007 May 29.
3
Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.胰腺癌的前驱病变:分子病理学及临床意义
Pancreatology. 2007;7(1):9-19. doi: 10.1159/000101873. Epub 2007 Apr 18.
4
Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.涉及双特异性磷酸酶6/丝裂原活化蛋白激酶磷酸酶-3(DUSP6/MKP-3)功能障碍的不同进展途径在胰腺上皮内瘤变和胰腺导管内乳头状黏液性肿瘤中的作用。
Mod Pathol. 2005 Aug;18(8):1034-42. doi: 10.1038/modpathol.3800383.
5
Cystic lesions of the pancreas.胰腺囊性病变
Mod Pathol. 2007 Feb;20 Suppl 1:S71-93. doi: 10.1038/modpathol.3800706.
6
Current understanding of precursors to pancreatic cancer.胰腺癌前体的当前认识。
J Hepatobiliary Pancreat Surg. 2007;14(3):217-23. doi: 10.1007/s00534-006-1165-6. Epub 2007 May 29.
7
Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia.胰腺大导管型浸润性腺癌伴微囊和乳头状结构:一种非浸润性导管肿瘤的潜在微观模拟。
Mod Pathol. 2012 Mar;25(3):439-48. doi: 10.1038/modpathol.2011.181. Epub 2011 Nov 4.
8
Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.切除胰腺多灶性导管内乳头状黏液性肿瘤患者的临床病理特征。
Surgery. 2012 Sep;152(3 Suppl 1):S74-80. doi: 10.1016/j.surg.2012.05.025. Epub 2012 Jul 6.
9
Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?我们能否预测癌前胰腺囊性肿瘤向导管腺癌的进展?
Future Oncol. 2022 Jul;18(23):2605-2612. doi: 10.2217/fon-2021-1545. Epub 2022 Jun 22.
10
Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.多个基因在胰腺导管内乳头状黏液性肿瘤中发生高甲基化。
Mod Pathol. 2008 Dec;21(12):1499-507. doi: 10.1038/modpathol.2008.157. Epub 2008 Sep 26.

引用本文的文献

1
Early neoplastic lesions of the pancreas: initiation, progression, and opportunities for precancer interception.胰腺早期肿瘤性病变:起始、进展及癌前阻断机会
J Clin Invest. 2025 Jul 15;135(14). doi: 10.1172/JCI191937.
2
Unlocking the Genetic Secrets of Pancreatic Cancer: Allelic Imbalances in Tumor Evolution.揭开胰腺癌的遗传奥秘:肿瘤进化中的等位基因失衡
Cancers (Basel). 2025 Apr 4;17(7):1226. doi: 10.3390/cancers17071226.
3
Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9.升高的固醇调节元件结合蛋白1通过靶向SOX9加速胰腺癌的起始和生长。
Biol Direct. 2025 Jan 14;20(1):6. doi: 10.1186/s13062-025-00595-1.
4
GI cancer mortality in participants in low dose CT screening for lung cancer with a focus on pancreatic cancer.肺癌低剂量CT筛查参与者中的胃肠道癌症死亡率,重点关注胰腺癌。
Sci Rep. 2024 Dec 2;14(1):29851. doi: 10.1038/s41598-024-76322-z.
5
Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions.用于胰腺癌的放射性药物:当前方法与未来方向综述
Pharmaceuticals (Basel). 2024 Oct 1;17(10):1314. doi: 10.3390/ph17101314.
6
PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration.通过空间数据整合揭示胰腺癌发生过程中的胰腺上皮内瘤变(PanIN)和癌症相关成纤维细胞(CAF)转变
Cell Syst. 2024 Aug 21;15(8):753-769.e5. doi: 10.1016/j.cels.2024.07.001. Epub 2024 Aug 7.
7
Exploring patient experiences of surveillance for pancreatic cystic neoplasms: a qualitative study.探索胰腺囊性肿瘤监测患者的体验:一项定性研究。
BMJ Open Gastroenterol. 2024 Jul 5;11(1):e001264. doi: 10.1136/bmjgast-2023-001264.
8
CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake.CYRI-B 介导线粒体吞噬作用通过溶血磷脂酸受体摄取促进转移。
Elife. 2024 May 7;13:e83712. doi: 10.7554/eLife.83712.
9
Selective epigenetic alterations in RNF43 in pancreatic exocrine cells from high-fat-diet-induced obese mice; implications for pancreatic cancer.高脂饮食诱导肥胖小鼠胰腺外分泌细胞中 RNF43 的选择性表观遗传改变;对胰腺癌的影响。
BMC Res Notes. 2024 Apr 15;17(1):106. doi: 10.1186/s13104-024-06757-0.
10
Cell of Origin of Pancreatic cancer: Novel Findings and Current Understanding.胰腺癌细胞起源:新发现和当前认识。
Pancreas. 2024 Mar 1;53(3):e288-e297. doi: 10.1097/MPA.0000000000002301. Epub 2024 Jan 26.

本文引用的文献

1
PancPRO: risk assessment for individuals with a family history of pancreatic cancer.PancPRO:胰腺癌家族史个体的风险评估
J Clin Oncol. 2007 Apr 10;25(11):1417-22. doi: 10.1200/JCO.2006.09.2452.
2
Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.帕拉丁基因突变导致家族性胰腺癌,并提示一种新的癌症机制。
PLoS Med. 2006 Dec;3(12):e516. doi: 10.1371/journal.pmed.0030516.
3
Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.胰腺导管内乳头状黏液性肿瘤(IPMN):两种主要类型之间的组织病理学差异。
Am J Surg Pathol. 2006 Dec;30(12):1561-9. doi: 10.1097/01.pas.0000213305.98187.d4.
4
A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients.卵巢型间质界定的胰腺黏液性囊性肿瘤综述:344例患者的临床病理特征
World J Surg. 2006 Dec;30(12):2236-45. doi: 10.1007/s00268-006-0126-1.
5
Precancer: a conceptual working definition -- results of a Consensus Conference.癌前病变:一个概念性的实用定义——共识会议结果
Cancer Detect Prev. 2006;30(5):387-94. doi: 10.1016/j.cdp.2006.09.002. Epub 2006 Oct 31.
6
A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients.胰腺囊性病变切除的选择性方法:539例连续患者的结果
Ann Surg. 2006 Oct;244(4):572-82. doi: 10.1097/01.sla.0000237652.84466.54.
7
Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.胰腺囊性病变患者的胰腺癌:197例患者的前瞻性研究
Clin Gastroenterol Hepatol. 2006 Oct;4(10):1265-70. doi: 10.1016/j.cgh.2006.07.013. Epub 2006 Sep 18.
8
Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.在有胰腺癌家族病史的患者中,与胰腺小叶萎缩相关的多灶性肿瘤前体病变。
Am J Surg Pathol. 2006 Sep;30(9):1067-76.
9
Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development.胰腺导管内乳头状黏液性肿瘤患者发生结直肠癌的风险很高。
Surgery. 2006 Jun;139(6):749-54. doi: 10.1016/j.surg.2005.11.008.
10
PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.胰腺导管内乳头状黏液性肿瘤/癌中的PIK3CA突变
Clin Cancer Res. 2006 Jun 15;12(12):3851-5. doi: 10.1158/1078-0432.CCR-06-0292.